Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IC19/1563 |
Trade Name | |
Synonyms | IC19 1563|IC19-1563|Autologous CAR-T cells IC19/1563 |
Drug Descriptions |
IC19/1563 are T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD19, which potentially induce toxicity in tumor cells expressing CD19 (NCI Drug Dictionary). |
DrugClasses | CD19 Immune Cell Therapy 62 |
CAS Registry Number | NA |
NCIT ID | C182623 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IC19/1563 | IC19/1563 | 0 | 1 |